9606 — Duality Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Duality Biotherapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,131	1,391	3,374
Net Total Accounts Receivable
Net Total Receivables	133	449	318
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,334	1,910	3,834
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.8	18.6	28.7
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,500	2,090	3,893
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,561	3,872	1,052
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,624	4,112	1,466
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1,124	-2,022	2,427
Total Liabilities & Shareholders' Equity	1,500	2,090	3,893
Total Common Shares Outstanding